» Articles » PMID: 34094433

Enhancing the ROS Generation Ability of a Rhodamine-decorated Iridium(iii) Complex by Ligand Regulation for Endoplasmic Reticulum-targeted Photodynamic Therapy

Overview
Journal Chem Sci
Specialty Chemistry
Date 2021 Jun 7
PMID 34094433
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The endoplasmic reticulum (ER) is a very important organelle responsible for crucial biosynthetic, sensing, and signalling functions in eukaryotic cells. In this work, we established a strategy of ligand regulation to enhance the singlet oxygen generation capacity and subcellular organelle localization ability of a rhodamine-decorated iridium(iii) complex by variation of the cyclometallating ligand. The resulting metal complex showed outstanding reactive oxygen species generation efficiency (1.6-fold higher than that of rose bengal in CHCN) and highly specific ER localization ability, which demonstrated the promise of the metal-based photo-theranostic agent by simultaneously tuning the photochemical/physical and biological properties. Additionally, low dark cytotoxicity, high photostability and selective tumour cell uptake were featured by this complex to demonstrate it as a promising candidate in photodynamic therapy (PDT) applications. near infrared fluorescence (NIRF) imaging and tumour PDT were investigated and showed preferential accumulation at the tumour site and remarkable tumour growth suppression, respectively.

Citing Articles

Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition autophagy-dependent ferroptosis.

Lu Y, Wang S, Li M, Liu R, Zhu M, Yang L Acta Pharm Sin B. 2025; 15(1):424-437.

PMID: 40041919 PMC: 11873580. DOI: 10.1016/j.apsb.2024.06.017.


Leveraging the Photofunctions of Transition Metal Complexes for the Design of Innovative Phototherapeutics.

Lee L, Lo K Small Methods. 2024; 8(11):e2400563.

PMID: 39319499 PMC: 11579581. DOI: 10.1002/smtd.202400563.


A BODIPY-Naphtholimine-BF Dyad for Precision Photodynamic Therapy, Targeting, and Dual Imaging of Endoplasmic Reticulum and Lipid Droplets in Cancer.

Chauhan N, Koli M, Ghosh R, Majumdar A, Ghosh A, Ghanty T JACS Au. 2024; 4(8):2838-2852.

PMID: 39211629 PMC: 11350743. DOI: 10.1021/jacsau.3c00539.


Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy.

Sheikh A, Kesharwani P, Almalki W, Salman Almujri S, Dai L, Chen Z Nanomicro Lett. 2024; 16(1):188.

PMID: 38698113 PMC: 11065855. DOI: 10.1007/s40820-024-01399-0.


Targeting the organelle for radiosensitization in cancer radiotherapy.

Sun X, Wu L, Du L, Xu W, Han M Asian J Pharm Sci. 2024; 19(2):100903.

PMID: 38590796 PMC: 10999375. DOI: 10.1016/j.ajps.2024.100903.


References
1.
Wang C, Wong K . Bichromophoric rhodamine-iridium(III) sensory system: modulation of the energy-transfer process through a selective sensing behavior. Inorg Chem. 2011; 50(12):5333-5. DOI: 10.1021/ic2006315. View

2.
Feng G, Liu B . Aggregation-Induced Emission (AIE) Dots: Emerging Theranostic Nanolights. Acc Chem Res. 2018; 51(6):1404-1414. DOI: 10.1021/acs.accounts.8b00060. View

3.
Deng K, Chen Y, Li C, Deng X, Hou Z, Cheng Z . 808 nm light responsive nanotheranostic agents based on near-infrared dye functionalized manganese ferrite for magnetic-targeted and imaging-guided photodynamic/photothermal therapy. J Mater Chem B. 2020; 5(9):1803-1814. DOI: 10.1039/c6tb03233h. View

4.
Dolmans D, Fukumura D, Jain R . Photodynamic therapy for cancer. Nat Rev Cancer. 2003; 3(5):380-7. DOI: 10.1038/nrc1071. View

5.
Nam J, Kang M, Kang J, Park S, Lee S, Kim H . Endoplasmic Reticulum-Localized Iridium(III) Complexes as Efficient Photodynamic Therapy Agents via Protein Modifications. J Am Chem Soc. 2016; 138(34):10968-77. DOI: 10.1021/jacs.6b05302. View